Zobrazeno 1 - 2
of 2
pro vyhledávání: '"E. B. Dalsgaard"'
Autor:
L.S. Andersen, Hanne Merete Lindegaard, Natalia Manilo, Susanne Højmark Jakobsen, Oliver Hendricks, Asta Linauskas, Dorte Dalsgaard Pedersen, B. L. Andersen, Henrik Nordin, Anne Gitte Loft, Salome Kristensen, Inge Juul Sørensen, Inger Marie Jensen Hansen, Frank Mehnert, Jakob Espesen, Emina Omerovic, Kamilla Danebod, E. B. Dalsgaard, B. Glintborg, Niels Steen Krogh, Jolanta Grydehøj, Stavros Chrysidis, D V Jensen, Johnny Lillelund Raun, Merete Lund Hetland
Publikováno v:
FRIDAY, 15 JUNE 2018.
Background In Denmark, patients (pts) treated with originator etanercept (ETA) 50 mg SC conducted a mandatory non-medical switch to biosimilar SB4 in April 2016 (switchers). Pts treated with 25 mg ETA or 50 mg powder-solution were not mandated to swi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68806fcd4fb47560dfb79a130e617b80
https://doi.org/10.1136/annrheumdis-2018-eular.2296
https://doi.org/10.1136/annrheumdis-2018-eular.2296
Autor:
Dorte Dalsgaard Pedersen, Emina Omerovic, Kamilla Danebod, Johnny Lillelund Raun, L.S. Andersen, Dorte Vendelbo Jensen, Natalia Manilo, Merete Lund Hetland, Anne Gitte Loft, Niels Steen Krogh, Oliver Hendricks, Hanne Merete Lindegaard, Asta Linauskas, Henrik Nordin, Inger Marie Jensen Hansen, Jakob Espesen, Susanne Højmark Jakobsen, Salome Kristensen, Frank Mehnert, B. L. Andersen, Inge Juul Sørensen, E. B. Dalsgaard, Stavros Chrysidis, Bente Glintborg, Jolanta Grydehøj
Publikováno v:
THURSDAY, 14 JUNE 2018.
Background In Denmark, rheumatoid arthritis(RA), psoriatic arthritis(PsA) and axial spondyloarthritis(AxSpA) patients (pts) treated with originator etanercept (ETA) 50 mg SC conducted a mandatory non-medical switch to biosimilar Etanercept (SB4) in A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9324aaf2ec8b0f9fbd6ac843fb9a02f6
https://doi.org/10.1136/annrheumdis-2018-eular.2113
https://doi.org/10.1136/annrheumdis-2018-eular.2113